1. Home
  2. VRAX vs MBOT Comparison

VRAX vs MBOT Comparison

Compare VRAX & MBOT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Virax Biolabs Group Limited

VRAX

Virax Biolabs Group Limited

N/A

Current Price

$2.86

Market Cap

2.3M

Sector

Health Care

ML Signal

N/A

Logo Microbot Medical Inc.

MBOT

Microbot Medical Inc.

HOLD

Current Price

$1.55

Market Cap

126.9M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
VRAX
MBOT
Founded
2013
2010
Country
United Kingdom
United States
Employees
26
N/A
Industry
Biotechnology: In Vitro & In Vivo Diagnostic Substances
Medical/Dental Instruments
Sector
Health Care
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
2.3M
126.9M
IPO Year
2021
2000

Fundamental Metrics

Financial Performance
Metric
VRAX
MBOT
Price
$2.86
$1.55
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
1
3
Target Price
$1.00
$7.50
AVG Volume (30 Days)
199.1K
545.7K
Earning Date
06-12-2026
05-15-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
60.27
EPS
N/A
N/A
Revenue
N/A
$116,887.00
Revenue This Year
$217,274.83
N/A
Revenue Next Year
N/A
$119.77
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$0.10
$1.60
52 Week High
$13.19
$4.62

Technical Indicators

Market Signals
Indicator
VRAX
MBOT
Relative Strength Index (RSI) 49.88 35.87
Support Level $0.19 N/A
Resistance Level $3.10 $2.21
Average True Range (ATR) 0.20 0.10
MACD -0.09 -0.02
Stochastic Oscillator 54.67 3.49

Price Performance

Historical Comparison
VRAX
MBOT

About VRAX Virax Biolabs Group Limited

Virax Biolabs Group Ltd is a biotechnology company focused on the detection of immune responses and the development of immune profiling and in vitro diagnostic technologies for viral and immune-mediated diseases, with a current strategic focus on post-acute infection syndromes (PAIS) and related areas of chronic immune dysfunction. The company's principal development activities are centered on T cell-based in vitro diagnostics and immune profiling. The company's flagship product candidate, ViraxImmune, is an in-development T cell-based assay and immune profiling platform intended to support the assessment of immune dysfunction, initially in PAIS indications.

About MBOT Microbot Medical Inc.

Microbot Medical Inc is a medical device company specializing in the research, design, and development of next-generation robotic endoluminal surgery devices targeting the minimally invasive surgery space. Using its LIBERTY technological platform, the company has developed the LIBERTY Endovascular Robotic Surgical System, a fully disposable robot for various endovascular interventional procedures. The company has a single operating and reportable segment, which is the development of robotic devices for endoluminal surgery.

Share on Social Networks: